[1] Qiu B,Jiang W,Mojtaba O,et al.Advances in the genome-wide association study of chronic hepatitis B susceptibility in Asian population.Eur J Med Res,2017,22:2088-2095.
[2] Sun YY,Fan C,Wang N,et al.Increased A20 mRNA level in peripheral blood mononuclear cells is associated with immune phases of patients with chronic hepatitis B.Medicine,2015,94:2428.
[3] 丁勇,许超,吴季辉等.表观遗传学研究进展中国科学,2017, 47:3-15.
[4] 朱峰,王旭,刘旭倩等.表观遗传学及其研究方法现代生物医学进展,2017, 17:2371-2376.
[5] Koumbi L,Karayiannis P.The epigenetic control of hepatitis B Virus modulates the outcome of infection.Front Microbiol, 2015,6:1491.
[6] Jin ZL,Liu Y.DNA methylation in human diseases.Genes&Diseases,2018, 31:1-8.
[7] Farcas AM,Blackledge NP,Sudbery L,et al.KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.Elife,2012,18:1-26.
[8] Genevieve S,Jenefer M,Blackwell,et al.Epigenetics in infectious diseases.Epigenetic Biomarkers and Diagnostics,2016,377-400.
[9] 凌青霞,陈明泉,施光峰,等.DNA甲基化修饰在乙肝病毒持续感染相关肝病中的研究现状.肝脏,2014, 19:362-364.
[10] Chiaho S,Yang CC,Gansukh C,et al.Hepatitis B virus.Trends Microbiol,2018,2: 1-2.
[11] Kostyushev DS,Zueva AP,Brezgin SV,et al.Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B.Ter Arkh,2017,89:21-26.
[12] Kostyushev DS,Zueva AP,Brezgin SA,et al.DNA methylation and human diseaseNat Rev Genet,2005,6,597-610.
[13] Zhang YM,Li CX,Zhang YJ,et al.Comparative analysis of CpG island among HBV genotypes.PLoS ONE,2013,8:e56711.
[14] Hou ZW,Huang JH,Zhong CY,et al.CpG islands of hepatitis B virus genome isolated from Chinese patientsGene,561,2015:261-267.
[15] Xue Y,Wang MJ,Huang SY,et al.Characteristics of CpG Islands and their quasispecies of full-length hepatitis B virus genomes from patients at different phases of infection.Springerplus, 2016,21:1186-1193.
[16] Zhao J,Fan YC,Chen LY,et al.Alteration of methyl-CpG binding domain family in patients with chronic hepatitis B.Clin Res Hepatol Gastroenterol,2017, 41:272-283.
[17] Wang YY,Hao JL,Liu XH,et al.The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.Lipids Health Dis,2016, 64:2-7.
[18] Madeddu G,Ortu S,Garrucciu G,et al.DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy.J Med Virol,2017,89:1208-1214.
[19] Hensel KO,Rendon JC,Navas MC,et al.Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies.FEBS J,2017,284:3550-3572.
[20] Liu XY,Fan YC,Gao S,et al.Hypermethylation of the N-Myc downstream-regulated gene 2 promoter in peripheral blood mononuclear cells is associated with liver fibrosis in chronic hepatitis B.Tohoku J Exp Med,2017,241:155-163.
[21] Zhang F,Fan YC,Mu NN,et al.Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.J Viral Hepat,2014,21:241-250.
[22] Qiao CY,Li F,Teng Y,et al.Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure.Clin Exp Med,2018, 18:51-62.
[23] Zhao J,Fan YC,Liu XY,et al.Hypermethylation of the galectin-3 promoter is associated with poor prognosis of acute-on-chronic hepatitis B liver failure.Dig Liver Dis,2017, 49:664-671.
[24] Zhang JJ,Fan YC,Zhang ZH,et al.Methylation of suppressor of cytokine signalling1 gene promoter is associated with acute-on-chronic hepatitis B liver failure.J Viral Hepat,2015,22:307-317.
[25] Liu XS,Wu H,Ji X,et al.Editing DNA methylation in the mammalian genome.Cell,2016,167:233-276. |
